Searched for
DRUG INNOVATION
ET Family Business Awards: Serum Institute, Mankind, Varun Beverages among winners in the limelight- As we look to the next decade, I hope in the future we can further grow in generics as we transition into drug innovation: Aman Mehta, MD, Torrent Pharmaceuticals
- Bye-bye painful dentist visit: A simple liquid could stop tooth decay; no drilling or injections needed for many cavities
- Karnataka discusses Takeda GCC expansion, innovation partnershipsKarnataka held discussions with Takeda Pharmaceutical leaders regarding their global capability center expansion. The talks focused on digi...29 Jul, 2026, 08.14 PM IST
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...28 Jul, 2026, 11.49 PM IST
- Alembic Pharma gets USFDA approval for generic chronic constipation treatment tabletsAlembic Pharmaceuticals announced USFDA approval for its generic prucalopride tablets. The company received final approval for strengths of...28 Jul, 2026, 03.46 PM IST
- 10,000-year-old disease that haunted Greeks and Chinese, weakened Civil War soldiers and caused 5% of 20th century deaths may finally have a weakness; Indian researchers find breakthroughScientists from India and Britain have identified a protein called Ark1 that acts as a control switch in the malaria parasite's cell divisi...27 Jul, 2026, 04.13 PM IST
- Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...27 Jul, 2026, 11.07 AM IST
- US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...26 Jul, 2026, 02.45 PM IST
- 'I expect India to be concerned about US pharma tariffs': Rubio on Trump's 200% stormUS Secretary of State Marco Rubio anticipates Indian concern over new generic drug import tariffs. These tariffs will rise significantly af...23 Jul, 2026, 09.07 AM IST
- Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...22 Jul, 2026, 01.58 PM IST
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...22 Jul, 2026, 12.48 PM IST
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...22 Jul, 2026, 12.42 PM IST
- Hikal commissions cGMP pilot plant in Pune to strengthen pharmaceutical developmentHikal has commissioned an enhanced cGMP pilot plant at its Pune campus to strengthen its integrated capabilities for pharmaceutical develop...22 Jul, 2026, 12.01 PM IST
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...22 Jul, 2026, 11.27 AM IST
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...22 Jul, 2026, 09.40 AM IST
- ICMR licenses cancer, vaccine technologies to Emcure, Biological EThe Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment an...22 Jul, 2026, 01.12 AM IST
- Glenmark sees innovative products driving 70% revenue in 5-6 years: CMD Glenn SaldanhaGlenmark anticipates innovative products will drive nearly seventy percent of its revenue. This strategic shift moves the company away from...22 Jul, 2026, 12.54 AM IST
- Glenmark gets USFDA nod for expanded use of RYALTRIS nasal sprayGlenmark Pharmaceuticals announced US FDA approval for RYALTRIS nasal spray. This approval expands its use to children aged six to twelve y...21 Jul, 2026, 02.01 PM IST
- Emcure Pharma gets CDSCO nod to market Poviztra for fatty liver treatmentEmcure Pharmaceuticals announced its brand Poviztra is now available for fatty liver treatment. This follows regulatory approval for treati...20 Jul, 2026, 06.35 PM IST
Load More
